ID   20842P
AC   CVCL_WM19
DR   cancercelllines; CVCL_WM19
DR   Cosmic; 852195
DR   IARC_TP53; 20609
DR   Wikidata; Q93301849
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly187Ser (c.559G>A); ClinVar=VCV000840399; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM26 ! 20842M1
OI   CVCL_WM46 ! 20842M2
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=15195137; DOI=10.1038/sj.onc.1207780;
RA   Daniotti M., Oggionni M., Ranzani T., Vallacchi V., Campi V.,
RA   Di Stasi D., Della Torre G., Perrone F., Luoni C., Suardi S.,
RA   Frattini M., Pilotti S., Anichini A., Tragni G., Parmiani G.,
RA   Pierotti M.A., Rodolfo M.;
RT   "BRAF alterations are associated with complex mutational profiles in
RT   malignant melanoma.";
RL   Oncogene 23:5968-5977(2004).
//